Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Pajewski

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEARTBharathi Upadhya, Michael V Rocco, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2016
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure StudyPaul E Drawz, Nicholas M Pajewski, Jeffrey T Bates, et al.
Journal of the American Heart Association|July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTLama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
Cell Reports. Medicine|June 21, 2023
Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspectiveFanny M Elahi, Suvarna Alladi, Sandra E Black, et al.
JAMA Cardiology|October 12, 2022
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical TrialByron C Jaeger, Adam P Bress, Joshua D Bundy, et al.
Diabetes|August 9, 2015
Genetic Predisposition to Weight Loss and Regain With Lifestyle Intervention: Analyses From the Diabetes Prevention Program and the Look AHEAD Randomized Controlled TrialsGeorge D Papandonatos, Qing Pan, Nicholas M Pajewski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2021
Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)Nicholas M Pajewski, Fanny M Elahi, Manjula Kurella Tamura, et al.
Contemporary Clinical Trials Communications|April 25, 2019
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study designMariana Murea, Randolph L Geary, Matthew S Edwards, et al.
Journal of the American College of Cardiology|April 23, 2021
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse EventsAdam P Bress, Tom Greene, Catherine G Derington, et al.
Neurology|May 2, 2025
Long-Term Effect of Intensive vs Standard Blood Pressure Control on Mild Cognitive Impairment and Probable Dementia in SPRINTDavid M Reboussin, Sarah A Gaussoin, Nicholas M Pajewski, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEARTBharathi Upadhya, Michael V Rocco, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2016
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure StudyPaul E Drawz, Nicholas M Pajewski, Jeffrey T Bates, et al.
Journal of the American Heart Association|July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTLama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
Cell Reports. Medicine|June 21, 2023
Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspectiveFanny M Elahi, Suvarna Alladi, Sandra E Black, et al.
JAMA Cardiology|October 12, 2022
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical TrialByron C Jaeger, Adam P Bress, Joshua D Bundy, et al.
Diabetes|August 9, 2015
Genetic Predisposition to Weight Loss and Regain With Lifestyle Intervention: Analyses From the Diabetes Prevention Program and the Look AHEAD Randomized Controlled TrialsGeorge D Papandonatos, Qing Pan, Nicholas M Pajewski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2021
Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)Nicholas M Pajewski, Fanny M Elahi, Manjula Kurella Tamura, et al.
Contemporary Clinical Trials Communications|April 25, 2019
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study designMariana Murea, Randolph L Geary, Matthew S Edwards, et al.
Journal of the American College of Cardiology|April 23, 2021
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse EventsAdam P Bress, Tom Greene, Catherine G Derington, et al.
Neurology|May 2, 2025
Long-Term Effect of Intensive vs Standard Blood Pressure Control on Mild Cognitive Impairment and Probable Dementia in SPRINTDavid M Reboussin, Sarah A Gaussoin, Nicholas M Pajewski, et al.
Pageof 16